What started as a way to gather nurse practitioners in the field of transplantation at Vanderbilt to talk about the best practices in managing patients has grown into a one-of-a-kind national conference.

Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure.

More than three decades ago, J. Harold Helderman, M.D., medical director of the Vanderbilt Transplant Center, joined a handful of colleagues from across the country to create a society for transplant physicians.

Despite a challenging health care landscape, Vanderbilt University Medical Center continues to advance the highest-quality patient care, train the next generation of physician leaders and push forward the frontiers of biomedical science.

A Vanderbilt University Medical Center postdoctoral research fellow in the area of transplant outcomes research has added health literacy as a metric to an existing battery of surveys that assess patient-reported outcomes in Vanderbilt transplant patients.

A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found.

Thanks to a series of altruistic donations that began in Colorado, three people who were waiting for a kidney received a life-saving transplant, including a patient at Vanderbilt University Medical Center.